Inmed pharmaceuticals to report full year fiscal 2022 financial results and business update on september 23, 2022

Vancouver, british columbia, sept. 19, 2022 (globe newswire) -- inmed pharmaceuticals inc. (“inmed” or the “company”) (nasdaq: inm), a leader in the research, development and manufacturing of rare cannabinoids, will report financial results on friday, september 23, 2022 for the fiscal year ended june 30, 2022.

INM Ratings Summary

INM Quant Ranking